The biotech sector is experiencing a significant influx of capital, highlighted by a recent $500 million funding round secured by the Venrock team, which now has over $1.1 billion available for investment. This surge in funding reflects a broader trend in venture capital, particularly for biotech startups, which rely heavily on such investments for growth. Additionally, BioPharma Dive has launched a new database that tracks biotech venture funding rounds, offering insights into investment patterns and trends within the industry. The database, developed by a team including Gwendolyn Wu, Ned Pagliarulo, and Julia Himmel, features interactive charts and lists, providing a comprehensive overview of funding activities in the sector.